Biotech Distilled
Substack ↗
Subscribe
Subscribe
Substack ↗
About
Research
Areas
Modalities
Phases
Targets
Track record
Movers
The Lead Compound
Home
›
Targets
› FAP
FAP
(2 companies · 2 programs)
Companies with an active program directed at FAP.
Immunome Inc.
IMNM
IM-3050
— Solid Tumors
Phase 1
MiNK Therapeutics, Inc.
INKT
MiNK-215
— Colorectal Cancer
Preclinical